Literature DB >> 25204526

[Macular telangiectasia type 2: The international MacTel project].

P Charbel Issa1, D Pauleikhoff, F G Holz.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25204526     DOI： 10.1007/s00347-014-3081-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  4 in total

1.  The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara A Blodi; Stacy M Meuer; Chelsea E Myers; Emily Y Chew; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2010-07       Impact factor: 5.258

Review 2.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

3.  Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.

Authors:  Hans-Martin Helb; Peter Charbel Issa; Rob L P VAN DER Veen; Tos T J M Berendschot; Hendrik P N Scholl; Frank G Holz
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

4.  Familial asymptomatic macular telangiectasia type 2.

Authors:  Mark C Gillies; Meidong Zhu; Emily Chew; Daniel Barthelmes; Edward Hughes; Haipha Ali; Frank G Holz; Hendrik P N Scholl; Peter Charbel Issa
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079
  4 in total
  1 in total

1.  Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity.

Authors:  Ramesh Venkatesh; Nikitha Gurram Reddy; Pranjal Mishra; Sameeksha Agrawal; Deepashri Mutalik; Naresh Kumar Yadav; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2022-04-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.